Improve engineering performance! We enhance components and design to ensure reliable fluid flow and efficiency.
The "Omega(TM) Membrane T-Series TFF Cassette" is a product that further evolves the Centramate and Centraset product lines, which have received high praise from customers. It offers a scalable membrane format with effective filtration areas (EFA) ranging from a minimum of 200 cm² to 0.5 m². This format can be applied to process development and small-scale production ranging from 0.1 L to approximately 125 L. 【Features】 - The screen materials on the supply and permeate sides use polypropylene, which has high resistance to sodium hydroxide. - Enlarged flow path ports on the supply and permeate sides achieve low pressure loss. - Designed to maximize mass transfer through the membrane. - Compared to conventional cassette shapes, it reduces processing time and membrane area. *For more details, please refer to the PDF document or feel free to contact us.*
Inquire About This Product
basic information
【Other Features】 ■Easy integration into processes ■Improved safety, reliability, and reproducibility ■High permeation flux and selectivity, along with low protein adsorption ■Enhanced performance of the process ■Easy scale-up for purification processes *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.